COA-019_MQ3W9_2024
Overview
Sub Description
SUPPORT TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES. (UNDISCLOSED BY PRIME)
Sub Awardee
Total Awarded
$814,583.58
Most Recent Award Date
Jan. 1, 2024
Place of Performance
United States
Prime Awardee
Prime Project Title
None
Prime Award
Award Hierarchy
Definitive Contract
Subcontract
COA-019_MQ3W9_2024
Related Subcontracts
Subcontracts under the same prime contract
Subcontract History
Disclosed subcontract actions
Prime Contract Details
Prime Status
Period of Performance
7/1/20
Start Date
10/19/25
Current End Date
10/19/25
Potential End Date
Obligations
$18.5M
Total Obligated
$18.5M
Current Value
$23.5M
Potential Value
Prime Overview
Original Description
TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.
Awarding / Funding Agency
NAICS
Not Reported
Pricing
Cost Plus Fixed Fee
Place of Performance
Boulder, CO 80301 United States
Set Aside
None
Extent Competed
Full And Open Competition